StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health total assets

Total assets on the balance sheet at the end of each period.

Aspira Women's Health's total assets was $4.44M at Jun 30, 2026. For fiscal 2025 it was $5.46M, down 0.6% from the year before. Over ten years it grew -12.6% a year on average. The highest annual figure on record is $41.08M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.46M-0.6%
FY2024Dec 31, 2024$5.49M-12.3%
FY2023Dec 31, 2023$6.26M-64.0%
FY2022Dec 31, 2022$17.37M-57.7%
FY2021Dec 31, 2021$41.08M+109.5%
FY2020Dec 31, 2020$19.61M+41.8%
FY2019Dec 31, 2019$13.83M+21.2%
FY2018Dec 31, 2018$11.41M+52.2%
FY2017Dec 31, 2017$7.50M-6.5%
FY2016Dec 31, 2016$8.02M-61.7%
FY2015Dec 31, 2015$20.96M-13.3%
FY2014Dec 31, 2014$24.17M-21.1%
FY2013Dec 31, 2013$30.64M+254.9%
FY2012Dec 31, 2012$8.63M-62.6%
FY2011Dec 31, 2011$23.11M-3.8%
FY2010Dec 31, 2010$24.04M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.44M-10.1%
Q1 FY2026Mar 31, 2026$5.09M-24.2%
Q4 FY2025Dec 31, 2025$5.46M-0.6%
Q3 FY2025Sep 30, 2025$7.30M+53.3%
Q2 FY2025Jun 30, 2025$4.93M-10.1%
Q1 FY2025Mar 31, 2025$6.72M-6.3%
Q4 FY2024Dec 31, 2024$5.49M-12.3%
Q3 FY2024Sep 30, 2024$4.76M-45.1%
Q2 FY2024Jun 30, 2024$5.49M-28.9%
Q1 FY2024Mar 31, 2024$7.16M-37.7%
Q4 FY2023Dec 31, 2023$6.26M-64.0%
Q3 FY2023Sep 30, 2023$8.66M-63.8%
Q2 FY2023Jun 30, 2023$7.72M-67.9%
Q1 FY2023Mar 31, 2023$11.50M-62.7%
Q4 FY2022Dec 31, 2022$17.37M-57.7%
Q3 FY2022Sep 30, 2022$23.94M-50.2%
Q2 FY2022Jun 30, 2022$24.02M-57.0%
Q1 FY2022Mar 31, 2022$30.86M-50.5%
Q4 FY2021Dec 31, 2021$41.08M+109.5%
Q3 FY2021Sep 30, 2021$48.05M+125.9%
Q2 FY2021Jun 30, 2021$55.83M+326.5%
Q1 FY2021Mar 31, 2021$62.30M+501.7%
Q4 FY2020Dec 31, 2020$19.61M+41.8%
Q3 FY2020Sep 30, 2020$21.27M+28.6%
Q2 FY2020Jun 30, 2020$13.09M-27.9%
Q1 FY2020Mar 31, 2020$10.35M+25.4%
Q4 FY2019Dec 31, 2019$13.83M+21.2%
Q3 FY2019Sep 30, 2019$16.53M+22.7%
Q2 FY2019Jun 30, 2019$18.15M+12.6%
Q1 FY2019Mar 31, 2019$8.25M+51.5%
Q4 FY2018Dec 31, 2018$11.41M+52.2%
Q3 FY2018Sep 30, 2018$13.47M+39.2%
Q2 FY2018Jun 30, 2018$16.12M+97.2%
Q1 FY2018Mar 31, 2018$5.45M-47.8%
Q4 FY2017Dec 31, 2017$7.50M-6.5%
Q3 FY2017Sep 30, 2017$9.68M-9.4%
Q2 FY2017Jun 30, 2017$8.17M–
Q1 FY2017Mar 31, 2017$10.44M–
Q4 FY2016Dec 31, 2016$8.02M–
Q3 FY2016Sep 30, 2016$10.68M–

More Aspira Women's Health figures

See a number that looks wrong?